Skip to content

Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

A Cross-sectional Study Describing the Current Status of Diagnosis and Treatment of Uroepithelial Cancer in Hospitals of Different Grades in Henan Province

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06663735
Enrollment
400
Registered
2024-10-29
Start date
2024-10-30
Completion date
2025-07-31
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uroepithelial Carcinoma

Keywords

Henan province, uroepithelial cancer, treatment

Brief summary

A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Detailed description

Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023 to December 31, 2023 A questionnaire was used to collect and analyze the treatment patterns of patients with early versus advanced uroepithelial cancer in different levels of hospitals in Henan Province.

Interventions

None listed

Sponsors

The First Affiliated Hospital of Xinxiang Medical College
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years of age (at enrollment) * Histologically confirmed uroepithelial carcinoma * Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma * Complete medical history information

Exclusion criteria

* Incomplete medical history and medical records

Design outcomes

Primary

MeasureTime frameDescription
Describing the diagnosis and treatment patterns of patients with early versus advanced uroepithelial carcinoma in different grades of hospitals in Henan Provinceup to the patients enrolled,an average of 1 yearTo describe the similarities and differences between the way patients with early and advanced uroepithelial cancer are diagnosed and treated in different levels of hospitals in Henan Province and the current guidelines for uroepithelial cancer.

Secondary

MeasureTime frameDescription
Comparison of differences in diagnosis and treatment patterns between patients with early-stage and advanced uroepithelial carcinoma in county hospitals and different consultation departments of the same hospital in Henan provinceup to the patients enrolled,an average of 1 yearThe main purpose of this study is to compare the differences between the diagnosis and treatment modalities and guidelines for early and advanced uroepithelial cancer patients in Henan Province in county hospitals. It also compares the differences in treatment modalities between different departments in the same level of hospitals.
Describing the pathology as well as genetic testing of patients with uroepithelial carcinoma in different grades of hospitals in Henan provinceup to the patients enrolled,an average of 1 year1. Proportion of different genes/proteins tested in patients with uroepithelial cancer (mutations in FGFR, HER2, HRR, ARID1A and CREBBP, TP53, CDKN2A and PD-L1 expression) 2. Proportion of early and advanced uroepithelial cancer patients with high expression/mutations of different genes and use of targeted therapies

Countries

China

Contacts

Primary ContactPing Lu, Professor
lupingdoctor@126.com86+13598722864
Backup ContactYana Zhang, Phd.
86+15093230340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026